申请人:Kato Tatsuya
公开号:US20100152457A1
公开(公告)日:2010-06-17
A method whereby a compound having HCV replication inhibitory activity and desired optical activity can be synthesized selectively and at high yield in a small number of steps by using a compound having a specific chiral auxiliary as a starting compound is provided.
A compound represented by the formula (1-8):
wherein Y represents a group represented by the following formula:
Q represents a protected carbonyl group; D represents —(CH
2
)
m
—R′, etc.; and n represents an integer of 0 to 10.